Therapeutic potential of Scleromitrion diffusum in gastric cancer treatment

Gastric cancer remains a major global health challenge, characterized by high mortality and limited therapeutic efficacy, especially in advanced stages. With conventional treatments like surgery and chemotherapy often yielding suboptimal outcomes and significant side effects, there is an urgent need for safer and more effective alternatives. Scleromitrion diffusum (Willd.), a traditional Chinese medicine (TCM) herb with a long history of use in oncology, has shown promising clinical potential against gastric cancer. This review systematically explores the bioactive components of S. diffusum and their multi-target mechanisms, integrating millennia of TCM wisdom with modern pharmacological evidence to provide a molecular basis for its anticancer efficacy.

Active anticancer compounds of S. diffusum

The therapeutic potential of S. diffusum is attributed to its diverse bioactive constituents, which include flavonoids, anthraquinones, terpenoids, sterols, and polysaccharides. Key flavonoids such as quercetin, kaempferol, and their glycosides exhibit potent anticancer activity by inhibiting proliferation, inducing apoptosis, and suppressing metastasis. Anthraquinones like 2-hydroxy-3-methylanthraquinone promote mitochondrial apoptosis, while terpenoids such as oleanolic acid and ursolic acid target oncogenic signaling pathways. Polysaccharides from S. diffusum enhance immune function by activating lymphocytes and macrophages, providing a dual mechanism of direct tumor suppression and immune potentiation.

Molecular pathways of S. diffusum in gastric cancer intervention

S. diffusum exerts its anticancer effects through a multi-pronged approach, targeting several critical pathways in gastric cancer pathogenesis:

  1. Induction of apoptosis: Flavonoids and anthraquinones activate both intrinsic and extrinsic apoptotic pathways. For instance, quercetin enhances caspase-3/9 activity and modulates the AMPK/mTOR and PI3K/AKT pathways, while kaempferol inhibits hTERT expression and telomerase activity, leading to programmed cell death.

  2. Promotion of ferroptosis: Quercetin induces ferroptosis by elevating lipid peroxidation and suppressing the NRF2/XCT antioxidant axis, offering a novel mechanism to combat gastric cancer.

  3. Inhibition of proliferation: Compounds like quercetin and oleanolic acid arrest the cell cycle at G0/G1 or G2/M phases by downregulating cyclin D1, CDK4, and MYC expression, thereby curbing uncontrolled cell division.

  4. Suppression of invasion and metastasisS. diffusum reverses epithelial-mesenchymal transition (EMT) by upregulating E-cadherin and downregulating vimentin and N-cadherin. Quercetin further inhibits metastasis by interfering with the uPA/uPAR system and NF-κB signaling.

  5. Inhibition of angiogenesis: Flavonoids such as quercetin and kaempferol suppress VEGF expression and signaling, disrupting tumor vascularization and nutrient supply.

  6. Enhancement of immune function: Polysaccharides and terpenoids modulate immune responses by activating dendritic cells, natural killer cells, and cytokine production, thereby creating an antitumor immune microenvironment.

Future research directions

Despite significant progress, several challenges remain. The poor solubility and bioavailability of active compounds like quercetin and ursolic acid limit their clinical application. Future research should focus on:

  • Structural modification of compounds to enhance efficacy and stability.

  • Development of nano-formulations and liposomal delivery systems to improve bioavailability.

  • Exploration of synergistic drug combinations, including integration with immunotherapy, to maximize therapeutic outcomes.

Conclusion

Scleromitrion diffusum represents a promising candidate for gastric cancer therapy, validated by both traditional use and modern scientific evidence. Its multi-compound, multi-pathway approach aligns with the holistic principles of TCM while offering mechanistic insights for precision oncology. By bridging traditional knowledge with contemporary research, S. diffusum exemplifies the potential of natural products in developing innovative, effective, and safer anticancer strategies. Future efforts should prioritize translational studies to harness its full clinical potential.

Source:
Journal reference:

Zhang, Y.-X., et al. (2025). Pharmacological Insights into Scleromitrion diffusum (Willd.) Against Gastric Cancer: Active Components and Mechanistic Pathways. Oncology Advances. doi.org/10.14218/ona.2025.00011

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Cervical cancer patients treated with radiation and chemotherapy report greater short-term decline in quality of life